Science and Technology Science and Technology
Thu, February 13, 2025

How Latent Labs Plans To Create Medicines From Scratch With AI


Published on 2025-02-13 06:42:17 - Forbes
  Print publication without navigation

  • Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development

Latent Labs, a startup founded by former Google DeepMind researchers, is leveraging artificial intelligence to revolutionize drug discovery by creating medicines from scratch. The company aims to design new drugs by using AI to understand and manipulate the molecular structures that could potentially treat various diseases. Their approach involves training AI models on vast datasets of molecular interactions and biological pathways to predict how new compounds might behave within the human body. This method not only speeds up the drug discovery process but also reduces costs and increases the likelihood of finding effective treatments for complex conditions like cancer, neurodegenerative diseases, and rare genetic disorders. By bypassing traditional trial-and-error methods, Latent Labs hopes to bring innovative therapies to market faster, addressing unmet medical needs and potentially transforming the pharmaceutical industry.

Read the Full Forbes Article at:
[ https://www.forbes.com/sites/davidprosser/2025/02/12/how-latent-labs-plans-to-create-medicines-from-scratch-with-ai/ ]